Gilder Gagnon Howe & Co’s Enzo Biochem, Inc. ENZ Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-763,219	Closed	-$3.96M	–	298
2018 Q2	$3.96M	Sell	763,219 -293,181	-28%	-$1.79M	0.04%	185
2018 Q1	$5.79M	Sell	1,056,400 -19,912	-2%	-$140K	0.07%	157
2017 Q4	$8.77M	Buy	1,076,312 +95,305	+10%	+$910K	0.12%	129
2017 Q3	$10.3M	Sell	981,007 -18,954	-2%	-$210K	0.14%	119
2017 Q2	$11M	Buy	999,961 +168,607	+20%	+$1.57M	0.16%	111
2017 Q1	$6.96M	Buy	831,354 +7,401	+0.9%	+$52.1K	0.12%	120
2016 Q4	$5.72M	Sell	823,953 -48,056	-6%	-$307K	0.11%	116
2016 Q3	$4.44M	Buy	872,009 +19,571	+2%	+$117K	0.08%	133
2016 Q2	$5.09M	Buy	852,438 +430,395	+102%	+$2.39M	0.1%	117
2016 Q1	$1.92M	Buy	422,043 +35,320	+9%	+$157K	0.04%	150
2015 Q4	$1.74M	Buy	+386,723	New	+$1.63M	0.03%	165

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gilder Gagnon Howe & Co's ENZ Position: Q3 2018 in Review

Gilder Gagnon Howe & Co sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 763,219 shares — an estimated $3.96M sold.

Gilder Gagnon Howe & Co first reported a position in ENZ in Q4 2015 and held it in 11 quarters. The position peaked at $11M in Q2 2017. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

Gilder Gagnon Howe & Co reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 763,219 Enzo Biochem, Inc. shares in Q3 2018, an estimated $3.96M.
Gilder Gagnon Howe & Co first reported a position in Enzo Biochem, Inc. in Q4 2015 and held it in 11 quarters.
Gilder Gagnon Howe & Co's Enzo Biochem, Inc. position peaked at $11M in Q2 2017.
101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2018, filed 30 Oct 2018.